Cite
HARVARD Citation
Kato, K. et al. (2018). Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: A phase I study. Cancer science. 109 (3), pp. 785-793. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kato, K. et al. (2018). Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: A phase I study. Cancer science. 109 (3), pp. 785-793. [Online].